KR880013974A - 합성펩티드와 이를 포함하는 제약학적 조성물 - Google Patents
합성펩티드와 이를 포함하는 제약학적 조성물 Download PDFInfo
- Publication number
- KR880013974A KR880013974A KR1019880006050A KR880006050A KR880013974A KR 880013974 A KR880013974 A KR 880013974A KR 1019880006050 A KR1019880006050 A KR 1019880006050A KR 880006050 A KR880006050 A KR 880006050A KR 880013974 A KR880013974 A KR 880013974A
- Authority
- KR
- South Korea
- Prior art keywords
- peptide
- arg
- ala
- lys
- gln
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims 20
- 239000008194 pharmaceutical composition Substances 0.000 title claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 title claims 2
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims 5
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 claims 3
- OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 claims 3
- -1 Phe Chemical compound 0.000 claims 2
- 231100000252 nontoxic Toxicity 0.000 claims 2
- 230000003000 nontoxic effect Effects 0.000 claims 2
- XKCWNEVAXQCMGP-RXMQYKEDSA-N (2R)-2-amino-5-[carbamimidoyl(methyl)amino]pentanoic acid Chemical compound CN(CCC[C@@H](N)C(O)=O)C(N)=N XKCWNEVAXQCMGP-RXMQYKEDSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims 1
- HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 claims 1
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 claims 1
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 claims 1
- SGCGMORCWLEJNZ-UWVGGRQHSA-N His-His Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1NC=NC=1)C([O-])=O)C1=CN=CN1 SGCGMORCWLEJNZ-UWVGGRQHSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (20)
- 하기 서열을 갖는 합성 펩티드, 또는 그의 비독성염 : (B) R1-R2-R3-Ala-Ile-Phe-Thr-R8-Ser-(Q1) R10-Arg-R12-(Q2) R13-Leu-R15-Gln-Leu-R18-(Q3) Ala-Arg-R21-(Q4) R22-Leu-R24-R25-Ile-R27-R28-Arg-Gln-Gln-Gly-Glu-R34-Asn-Gln-Glu-R38-R39-R40-Arg-R42-R43-R44여기서 R1은 Tyr, D-Tyr, Met, Phe, D-Phe, PCl-Phe, Leu, His 또는 D-His ; B는 H, CaMe, NaMe, 데스아미노 Ac 또는 For ; R2는 Ala, D-Ala, NMA 또는 D-NMA ; R3은 Asp 또는 D-Asp ; R8은 Ser, Asn, Lys, Arg, Asp 또는 Gln ; R10은 Tyr, D-Tyr 또는 Phe ; R12은 Arg 또는 Lys ; R13은 Ile, Val, Leu 또는 Ala ; R15은 Gly 또는 Ala ; R18은 Ser 또는 Tyr ; R21은 Lys, D-Lys, Arg 또는 D-Arg ; R22은 Leu, Ile, Ala 또는 Val, ; R24은 Gln 또는 His ; R25은 Asp 또는 Glu ; R27은 Met, D-Met, Ala, Nle, Ile, Le나, Nva 또는 Val ; R28은 Asn 또는 Ser ; R34은 Ser 또는 Arg ; R38은 Arg 또는 Gln ; R39은 Gly 또는 Arg ; R40은 Ala 또는 Ser ; R42은 Phe, Ala 또는 Val ; R43은 Asn 또는 Arg ; R44은 천연아미노산 ; Q2-Q4은 H 또는 CaMe 이며, 단 R30과 R44사이의 어떤 또는 모든 잔기가 제거될 수 있으며, 또한 단, Q1-Q4의 적어도 하나는 CaMe 이며/이거나 R8은 Lys 또는 Arg이며/이거나 R21은 D-Lys 또는 D-Arg 이다.
- 제 1항에 있어서, R18이 Ser 이며, R24가 Gln이며, R25가 Asp이며 R34가 Ser이며, R38이 Arg 이며 R39가 Gly이며 R40이 Ala인 펩티드.
- 제 1항 또는 제 2항에 있어서, R8이 Lys인 펩티드.
- 제 1항 내지 제 3항중 어느 한 항에 있어서, R21이 D-Arg인 펩티드.
- 제 1항 내지 제 3항중 어느 한 항에 있어서, R21이 D-Lys인 펩티드.
- 제 1항 내지 제 5항중 어느 한 항에 있어서, R22가 Leu인 펩티드.
- 제 1항 내지 제 6항중 어느 한 항에 있어서, R27이 Nle인 펩티드.
- 제 1항 내지 제 7항중 어느 한 항에 있어서, R15가 Ala인 펩티드.
- 제 1항 내지 제 8항중 어느 한 항에 있어서, R28이 Asn인 펩티드.
- 제 1항 내지 제 9항중 어느 한 항에 있어서, Q1이 CaMe인 펩티드.
- 제 1항 내지 제 10항중 어느 한 항에 있어서, Q2가 CaMe인 펩티드.
- 제 1항 내지 제 11항중 어느 한 항에 있어서, Q3이 CaMe인 펩티드.
- 제 1항 내지 제 12항중 어느 한 항에 있어서, Q4가 CaMe인 펩티드.
- 제 1항에 있어서 식[NaMeTyr1, Asp8, Ala15, Nle27, Asn28]-hGRF(1-29)-NH2를 갖는 펩티드.
- 제 1항에 있어서 식[NaMeTyr1, Lys8, Ala15, Nle27, Asn28]-hGRF(1-29)-NH2를 갖는 펩티드.
- 제 1항에 있어서 식[NaMeTyr1, D-Lys21, Nle27]-hGRF(1-29)-NH2를 갖는 펩티드.
- 제 1항에 있어서 식[NaMeTyr1, D-Tyr10, D-Lys21, Nle27]hGRF(1-29)-NH2를 갖는 펩티드.
- 제 1항 내지 제 13항 중 어느 한 항에 있어서, R8이 Lys이며, R27이 Nle이며 잔기 30 내지 44이 제거된 펩티드.
- 제 1항 내지 제 18항 중 어느 한 항의 펩티드 또는 그의 비독성열과 제약학 또는 수의학적으로 허용가능한 그에 대한 액체 또는 고형 담체를 포함하는 동물에서 GH방출을 자극하기 위한 제약학적 조성물.
- 제 19항에 따르는 조성물을 효과적인 양 만큼 투여하는 것을 포함하는 인간의 치료처치를 위한 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/053,235 US5002931A (en) | 1987-05-22 | 1987-05-22 | GRF analogs VII |
US053235 | 1987-05-22 | ||
US053,235 | 1987-05-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR880013974A true KR880013974A (ko) | 1988-12-22 |
KR0143913B1 KR0143913B1 (ko) | 1998-07-01 |
Family
ID=21982813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880006050A KR0143913B1 (ko) | 1987-05-22 | 1988-05-21 | 합성 펩티드와 이를 포함하는 제약학적 조성물 |
Country Status (14)
Country | Link |
---|---|
US (1) | US5002931A (ko) |
EP (1) | EP0292334A3 (ko) |
JP (1) | JP2758901B2 (ko) |
KR (1) | KR0143913B1 (ko) |
AU (1) | AU1647788A (ko) |
CA (1) | CA1312704C (ko) |
DK (1) | DK280088A (ko) |
FI (1) | FI89499C (ko) |
HU (1) | HUT46932A (ko) |
IL (1) | IL86166A0 (ko) |
NO (1) | NO882184L (ko) |
PT (1) | PT87529B (ko) |
SU (1) | SU1598881A3 (ko) |
ZA (1) | ZA882832B (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4734399A (en) * | 1985-08-06 | 1988-03-29 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
US5098995A (en) * | 1987-05-22 | 1992-03-24 | The Salk Institute For Biological Studies | GRF Analogs VIIA |
ATE106895T1 (de) * | 1987-09-18 | 1994-06-15 | Hoffmann La Roche | Zyklische grf-analoga. |
AU4955490A (en) * | 1989-01-27 | 1990-08-24 | Upjohn Company, The | Stabilized, potent grf analogs |
EP0544706A4 (en) * | 1990-06-29 | 1993-10-13 | Hoffmann-La Roche Inc. | Histidine substituted growth hormone releasing factor analogs |
EP0490249B1 (en) * | 1990-12-10 | 1995-03-15 | F. Hoffmann-La Roche Ag | Process for the enzymatic preparation of GRF(1-44)NH2 |
WO1992018531A1 (en) * | 1991-04-09 | 1992-10-29 | F. Hoffmann-La Roche Ag | Growth hormone releasing factor analogs |
US5262519A (en) * | 1991-05-15 | 1993-11-16 | The Salk Institute For Biological Studies | GRF analogs XI |
CA2158782C (en) * | 1994-09-23 | 2010-01-12 | Pierrette Gaudreau | Marker for growth hormone-releasing factor receptors |
AU5441096A (en) * | 1995-04-14 | 1996-10-30 | The Administrators Of The Tulane Eductional Fund | Analogs of growth hormone-releasing factor |
US7963352B2 (en) * | 2003-08-18 | 2011-06-21 | Engineering Recreation (2008) Limited | Powered unicycle |
US8800697B2 (en) | 2009-09-01 | 2014-08-12 | Ryno Motors, Inc. | Electric-powered self-balancing unicycle with steering linkage between handlebars and wheel forks |
EP2888155A4 (en) | 2012-08-22 | 2016-08-03 | Ryno Motors Inc | AUTOMATIC BALANCING ELECTRICAL MONOCYCLE |
USD739307S1 (en) | 2013-04-30 | 2015-09-22 | Ryno Motors, Inc. | One-wheeled vehicle |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4595676A (en) * | 1983-04-26 | 1986-06-17 | The Salk Institute For Biological Studies | Rat hypothalamic GRF |
US4518586A (en) * | 1983-01-13 | 1985-05-21 | The Salk Institute For Biological Studies | GRF Analogs III |
AU575843B2 (en) * | 1983-08-10 | 1988-08-11 | The Administrators Of The Tulane Eductional Fund | Growth hormone releasing peptides |
US4626523A (en) * | 1983-09-13 | 1986-12-02 | The Salk Institute For Biological Studies | GRF analogs II |
US4528190A (en) * | 1983-10-25 | 1985-07-09 | The Salk Institute For Biological Studies | GRF Analogs IV |
CA1271600A (en) * | 1985-01-07 | 1990-07-10 | David Howard Coy | Growth hormone-releasing peptides and method of treating mammals therewith |
US4689318A (en) * | 1985-08-29 | 1987-08-25 | The Salk Institute For Biological Studies | GRF analogs |
US4784987A (en) * | 1987-01-13 | 1988-11-15 | The Salk Institute For Biological Studies | GRF analogs VI |
US4801456A (en) * | 1987-07-09 | 1989-01-31 | International Minerals & Chemical Corp. | Growth hormone-releasing factor analogs |
-
1987
- 1987-05-22 US US07/053,235 patent/US5002931A/en not_active Expired - Lifetime
-
1988
- 1988-04-21 ZA ZA882832A patent/ZA882832B/xx unknown
- 1988-04-25 IL IL86166A patent/IL86166A0/xx not_active IP Right Cessation
- 1988-05-16 SU SU884355674A patent/SU1598881A3/ru active
- 1988-05-17 FI FI882305A patent/FI89499C/fi not_active IP Right Cessation
- 1988-05-19 PT PT87529A patent/PT87529B/pt not_active IP Right Cessation
- 1988-05-19 NO NO882184A patent/NO882184L/no unknown
- 1988-05-20 HU HU882610A patent/HUT46932A/hu unknown
- 1988-05-20 DK DK280088A patent/DK280088A/da not_active Application Discontinuation
- 1988-05-20 CA CA000567405A patent/CA1312704C/en not_active Expired - Fee Related
- 1988-05-20 AU AU16477/88A patent/AU1647788A/en not_active Abandoned
- 1988-05-21 KR KR1019880006050A patent/KR0143913B1/ko not_active IP Right Cessation
- 1988-05-23 EP EP88304663A patent/EP0292334A3/en not_active Withdrawn
- 1988-05-23 JP JP63125602A patent/JP2758901B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0292334A2 (en) | 1988-11-23 |
PT87529B (pt) | 1992-09-30 |
FI882305A0 (fi) | 1988-05-17 |
EP0292334A3 (en) | 1990-06-27 |
IL86166A0 (en) | 1988-11-15 |
FI882305A (fi) | 1988-11-23 |
JPS649999A (en) | 1989-01-13 |
NO882184L (no) | 1988-11-23 |
AU1647788A (en) | 1988-11-24 |
FI89499C (fi) | 1993-10-11 |
CA1312704C (en) | 1993-01-12 |
US5002931A (en) | 1991-03-26 |
ZA882832B (en) | 1988-11-11 |
DK280088D0 (da) | 1988-05-20 |
PT87529A (pt) | 1989-05-31 |
NO882184D0 (no) | 1988-05-19 |
JP2758901B2 (ja) | 1998-05-28 |
HUT46932A (en) | 1988-12-28 |
DK280088A (da) | 1988-11-23 |
FI89499B (fi) | 1993-06-30 |
SU1598881A3 (ru) | 1990-10-07 |
KR0143913B1 (ko) | 1998-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL75088A (en) | Peptides being grf analogs and pharmaceutical compositions containing them | |
KR880013974A (ko) | 합성펩티드와 이를 포함하는 제약학적 조성물 | |
EP0696208A4 (en) | ORAL DELIVERY FORM AND METHOD | |
NZ217280A (en) | Lgrf derivatives and pharmaceutical compositions | |
KR910002900A (ko) | 합성 펩티드 및 이를 함유하는 제약학적 조성물 | |
KR930701483A (ko) | Grf (쥐이알에프) 유사체 xi | |
IE880302L (en) | Polypeptides | |
KR930701486A (ko) | Crf (씨이 알 에프) 유사체 | |
RU95120588A (ru) | Циклогексапептиды, их смеси, способ их получения и применения | |
KR890005149A (ko) | 합성 펩타이드 및 이를 포함한 제약학적 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
B901 | Examination by re-examination before a trial | ||
B90T | Transfer of trial file for re-examination | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20040402 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |